Problem statement: Answer the multiple-choice question.
Question: Which drug has a -49.129% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCCCn1nc(C(=O)NCC2COc3ccccc3O2)c2ccccc2c1=O
b: COc1cc(OC)c(OC)cc1/C=C1\Oc2cc(OCC(=O)N3Cc4ccccc4C[C@H]3C(=O)O)ccc2C1=O
Answer: a. CCCCn1nc(C(=O)NCC2COc3ccccc3O2)c2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCn1nc(C(=O)NCC2COc3ccccc3O2)c2ccccc2c1=O
CCCCn1nc(C(=O)NCC2COc3ccccc3O2)c2ccccc2c1=O
3-butyl-N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-4-oxophthalazine-1-carboxamide